Last reviewed · How we verify

Restylane-L® Lyft

University of Pennsylvania · FDA-approved active Small molecule

Restylane-L Lyft is a hyaluronic acid-based dermal filler that adds volume and structure to facial tissues to correct moderate to severe facial folds and wrinkles.

Restylane-L Lyft is a hyaluronic acid-based dermal filler that adds volume and structure to facial tissues to correct moderate to severe facial folds and wrinkles. Used for Correction of moderate to severe facial wrinkles and folds, Facial volume restoration and contouring.

At a glance

Generic nameRestylane-L® Lyft
Also known asHyaluronic acid gel
SponsorUniversity of Pennsylvania
Drug classDermal filler
ModalitySmall molecule
Therapeutic areaDermatology / Aesthetics
PhaseFDA-approved

Mechanism of action

The product consists of cross-linked hyaluronic acid particles suspended in a gel carrier that integrates into the dermis, providing immediate volumization and stimulating collagen production over time. Hyaluronic acid is a naturally occurring polysaccharide that binds water molecules, maintaining hydration and elasticity in the skin. The cross-linking technology allows the filler to maintain its structure and provide sustained lifting and volumizing effects.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: